🇺🇸 FDA
Patent

US 6060500

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

expired A61KA61K31/00A61K31/05

Quick answer

US patent 6060500 (Suppression, by 5-lipoxygenase inhibitors, of bone resorption) held by The Board of Regents of the University of Texas System expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/00, A61K31/05, A61K31/405, A61K31/47